A Sham-Controlled Trial of AF Ablation Is Feasible, but Is It Needed?
Although ORBITA-AF shows it can be done, and other trials are underway, not everyone is convinced it’s worth the effort.
Although ORBITA-AF shows it can be done, and other trials are underway, not everyone is convinced it’s worth the effort.
The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.
Steward Health Care, the struggling hospital group that owns hospitals in Massachusetts, Texas, Florida and other states, announced Monday that it is filing for bankruptcy.
Cardiovascular events frequently recur after acute myocardial infarction, and low cholesterol efflux — a process mediated by apolipoprotein A1, which is the main protein in…
As every year, the AcuteCVdays Campaign will run from April 29th until June 2nd. The 2024 edition will focus on “An update on device-therapy in…
May 2, 2024 — Reprieve Cardiovascular, Inc. (‘Reprieve’), a development stage company focused on pioneering an intelligent approach to acute decompensated heart failure (ADHF) treatment, today highlighted…
May 2, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the primary…
May 2, 2024 — Artificial intelligence experts at Cedars-Sinai and the Smidt Heart Institute created a dataset with more than 1 million echocardiograms, or cardiac…
Correspondence to: Rishi K. Wadhera, MD, MPP, MPhil, Section of Health Policy and Equity at the Richard A. and Susan F. Smith Center for Outcomes…
The study published in Neurology Clinical Practice states that people who take acid-reducing drugs may have a higher risk of migraine and other severe headache…
Developed by doctors, MedShr is the easiest & safest way for medical professionals to discover, discuss and share clinical cases and medical images. Join our…